12,740 Intuitive Surgical, Inc. $ISRG Shares Acquired by One Way Holdings LLC

One Way Holdings LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 53.5% in the third quarter, according to its most recent filing with the SEC. The fund owned 36,569 shares of the medical equipment provider’s stock after acquiring an additional 12,740 shares during the period. One Way Holdings LLC’s holdings in Intuitive Surgical were worth $14,870,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Bank of New York Mellon Corp bought a new position in Intuitive Surgical in the second quarter valued at about $1,335,753,000. Arrowstreet Capital Limited Partnership grew its holdings in shares of Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Assenagon Asset Management S.A. increased its stake in shares of Intuitive Surgical by 55.8% in the third quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock valued at $633,505,000 after buying an additional 558,099 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Intuitive Surgical in the third quarter valued at approximately $136,743,000. Finally, Amundi increased its stake in shares of Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after buying an additional 193,096 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $432.01 on Monday. The stock has a market capitalization of $149.75 billion, a price-to-earnings ratio of 52.24, a PEG ratio of 2.98 and a beta of 1.45. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The stock’s 50 day moving average price is $401.54 and its two-hundred day moving average price is $434.05.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company’s quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.40 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 20,095 shares of Intuitive Surgical stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the sale, the director directly owned 1,204,530 shares of the company’s stock, valued at approximately $543,977,793.30. The trade was a 1.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the company’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the transaction, the vice president owned 1,026 shares in the company, valued at $464,993.46. This represents a 79.78% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 38,778 shares of company stock worth $16,814,967 over the last ninety days. 0.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts recently commented on ISRG shares. JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $450.00 to $475.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 21st. Truist Financial lowered their price target on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating for the company in a report on Thursday, July 16th. TD Cowen restated a “buy” rating and issued a $485.00 price target on shares of Intuitive Surgical in a research report on Monday, October 19th. BNP Paribas Exane raised shares of Intuitive Surgical to an “outperform” rating in a research note on Tuesday, July 28th. Finally, Robert W. Baird upped their price objective on shares of Intuitive Surgical from $513.00 to $550.00 and gave the company an “outperform” rating in a research note on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $493.54.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.